Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study

By Tfelt-Hansen P.   Bach F.   Daugaard D.   Tsiropoulos I.   Riddersholm B.  

The Journal of Headache and Pain, Vol. 7, Iss. 6, 2006-12 ,pp. : 389-394

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of a New Formulation of Sumatriptan Tablets when Administered Early in a Migraine Attack

By Carpay Hans   Cruccu Giorgio   Boswell Diane   Kinrade Frances   Jones Martin  

Headache Care, Vol. 1, Iss. 1, 2004-03 ,pp. : 60-62

Informa Healthcare

Access to resources Recommend Favorite

A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine

By Dahlöf Carl   Jones Martin   Davis Kim   Loftus Jane   Salonen Reijo  

The Journal of Headache and Pain, Vol. 5, Iss. 2, 2004-08 ,pp. : 115-122

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Tolerability of Eletriptan vs. Sumatriptan 100 mg for the Acute Treatment of Migraine

By Hettiarachchi J.   Rasmussen S.   Sikes C.   Sun W.  

Headache Care, Vol. 1, Iss. 1, 2004-03 ,pp. : 43-45

Informa Healthcare

Access to resources Recommend Favorite

A Prospective Randomized Comparison of Early vs. Late Intervention During a Migraine Attack: Early Intervention Increases the Efficacy of Sumatriptan

By Scholpp Joachim   Schellenberg Ruediger   Moeckesch Beate   Banik Norbert  

Headache Care, Vol. 1, Iss. 1, 2004-03 ,pp. : 57-59

Informa Healthcare

Access to resources Recommend Favorite